Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Updated core content: added government operating status notice, added a new malignant lymphoma term, and updated revision to v3.2.0; removed an older lymphoma classification and earlier revision v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T08:31:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added a more precise diagnostic label for a B-cell lymphoma and updated the revision version to v3.1.0, while removing the older, less formal phrasing and the previous version v3.0.2 term.
    Difference
    0.7%
    Check dated 2025-09-28T03:01:18.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:44:17.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-06T15:29:44.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of new lymphoma types and the facility name, while also removing several previously listed lymphoma types and location details.
    Difference
    2%
    Check dated 2025-08-30T12:13:10.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-23T08:08:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.